SCHEMBL30038307

SCHEMBL30038307

O=[N+]([O-])c1c(F)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ CYP3A4 P08684 4/20 0.53
▸ TDP1 Q9NUW8 3/20 0.53
▸ HPGD P15428 2/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ TXNRD1 Q16881 1/20 0.53
▸ TXNRD3 Q86VQ6 1/20 0.53
▸ TXNRD2 Q9NNW7 1/20 0.53
▸ PTPN5 P54829 1/20 0.38
▸ FGFR4 P22455 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ EPAS1 Q99814 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2792876 1.00 TSHR (0.53) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL16174996 0.89 TSHR (0.60) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL3325206 0.87 ALDH1A1 (0.52) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL31346023 0.82 TDP1 (0.53) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL5872583 0.77 ALDH1A1 (0.72) TSHRALDH1A1TDP1HPGDHIF1A
SCHEMBL23302367 0.77 ALDH1A1 (0.48) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL29896834 0.77 ALDH1A1 (0.48) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL31495114 0.77 TDP1 (0.47) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL29805021 0.75 CYP3A4 (0.68) TSHRALDH1A1CYP3A4TDP1HPGD
SCHEMBL1531127 0.75 CYP3A4 (0.68) TSHRALDH1A1CYP3A4TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049746-A1 COMPOSITIONS COMPRISING WERNER SYNDROME HELICASE INHIBITORS AND METHODS OF USING THE SAME EIKON THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
CN-119424423-A 4-Aminobut-2-enamide derivatives and salts thereof 大鹏药品工业株式会社 2025-02-14 — — CN disclosed
EP-4329750-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT Merck Sharp & Dohme LLC (US) 2024-03-06 — — EP disclosed
CN-115551500-A 4-aminobut-2-enamide derivatives and salts thereof 大鹏药品工业株式会社 2022-12-30 — — CN disclosed
WO-2022232320-A1 SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT MERCK SHARP & DOHME CORP. (US) 2022-11-03 — — WO disclosed
Send feedback